4 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 4 of 4 clinical reviews.
A guide to rapamycin (sirolimus) side effects, with a focus on potentially permanent adverse events, real trial data, FDA label warnings, and clinical decision guidance.
A guide to the rare but serious adverse events of rapamycin (sirolimus), covering pulmonary toxicity, opportunistic infections, impaired wound healing, and more, with citations from clinical trials, FDA labeling, and post-market surveillance.
A breakdown of rapamycin (sirolimus) adverse events by severity grade and patient phenotype, drawing on FDA labeling, FAERS data, and key transplant and longevity trials.
A deep look at what happens when rapamycin (sirolimus) is stopped abruptly or tapered, including rebound immunologic activity, graft rejection risk, mTOR reactivation, and practical discontinuation protocols backed by primary-source evidence.